Rapamycin — also known as sirolimus — has become one of the most discussed molecules in longevity medicine. Originally an FDA-approved medication used in transplant patients, it's drawn intense research interest for a different reason: in studies, it's one of the few compounds shown to extend lifespan in animals, by acting on a master regulator of aging called mTOR. Its use for longevity is off-label and still being studied. Here's how it works, what the research shows, and why it requires careful medical supervision.
Important: Rapamycin is FDA-approved for specific medical uses (such as in transplant patients). Its use for longevity is off-label and investigational, and it must be used only under close medical supervision.
Rapamycin (sirolimus) is a medication first discovered in soil bacteria and long used clinically for its immune-modulating effects. What reignited interest is its action on mTOR — “mechanistic target of rapamycin” — a cellular pathway that controls growth, metabolism, and aging. Dialing down mTOR activity is associated in research with many of the benefits seen with caloric restriction, without the diet.
mTOR is a kind of cellular accelerator: when it's highly active, cells grow and divide; when it's dialed back, cells shift toward maintenance, repair, and a clean-up process called autophagy that clears out damaged components. Aging is associated with chronically over-active mTOR. By inhibiting it intermittently, rapamycin is studied for promoting that repair-and-clean-up state — which in animal research has translated to longer, healthier lifespan. In people, longevity use typically involves low, intermittent dosing, a strategy still under active study.
Ready to feel like the best version of yourself?
Schedule Your ConsultationIn longevity research, rapamycin is studied for:
It's important to be measured: the strongest evidence is from animal studies, human longevity use is still being researched, and rapamycin is a real medication with real effects — which is exactly why it belongs only in a carefully supervised plan.
Rapamycin affects the immune system and metabolism, and it has known side effects that depend heavily on dose and how it's used. Longevity protocols aim to minimize these with low, intermittent dosing, but it still requires careful screening, lab monitoring, and a knowledgeable provider — it is not a supplement to experiment with. The specific protocol is an individualized clinical decision; we don't publish dosing.
Rapamycin tends to interest adults focused on longevity and healthy aging who want a medically supervised, evidence-aware approach. Whether it's appropriate for you is a careful clinical judgment based on your health, labs, and goals, reviewed in a consultation — often alongside broader hormone optimization.
Rapamycin for longevity is provided only within a physician-supervised plan with thorough screening, lab monitoring, and careful, conservative protocols — by providers who follow the research closely. In person at our Scottsdale clinic or by concierge virtual visit across Arizona.
Rapamycin (sirolimus) is FDA-approved for specific medical uses such as in transplant patients. It's also studied off-label for longevity and healthy aging through its effect on the mTOR pathway.
It inhibits mTOR, shifting cells toward repair and autophagy (clean-up) — a state associated with longer, healthier lifespan in animal research. Longevity use typically involves low, intermittent dosing.
Longevity use is off-label and still being researched. Rapamycin affects immunity and metabolism and has real side effects, so it requires careful screening, lab monitoring, and close medical supervision.
Book a consultation — in person at our Scottsdale clinic or by concierge virtual visit across Arizona. We'll review your goals and history and tell you honestly whether rapamycin is an appropriate option for you.
Customized hormone, peptide, weight-loss, and aesthetic plans built around your body and lifestyle. Confidential consultations available in-office and via telemedicine.
Book Your Consultation